España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ImmunoPrecise Antibodies
IPA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.4001
-0.02
-4.76%
At close: -
$0.4098
0.00970
2.42%
After Hours: Dec 20, 4:55 PM EDT
Get Report
Comment
ImmunoPrecise Antibodies (IPA) Forecast
News
Earnings
ImmunoPrecise Antibodies (IPA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ImmunoPrecise Antibodies (NASDAQ:IPA) Stock
ImmunoPrecise Antibodies Stock (NASDAQ: IPA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 11, 2024
HC Wainwright & Co. Maintains Buy on ImmunoPr...
Benzinga Newsdesk
Tuesday, December 10, 2024
ImmunoPrecise Antibodies Q2 2025 GAAP EPS C$(...
Benzinga Newsdesk
ImmunoPrecise Antibodies: Q2 Earnings Insights
Benzinga Insights
Earnings Scheduled For December 10, 2024
Benzinga Insights
Monday, December 09, 2024
A Preview Of ImmunoPrecise Antibodies's Earnings
Benzinga Insights
Monday, October 28, 2024
ImmunoPrecise Highlights Publication Of Mayo ...
Benzinga Newsdesk
Wednesday, October 02, 2024
ImmunoPrecise Antibodies And Biotheus Enter A...
Benzinga Newsdesk
Thursday, September 26, 2024
ImmunoPrecise Antibodies Advances Therapeutic...
Benzinga Newsdesk
Tuesday, September 17, 2024
HC Wainwright & Co. Reiterates Buy on ImmunoP...
Benzinga Newsdesk
Monday, September 16, 2024
ImmunoPrecise Antibodies shares are trading l...
Benzinga Newsdesk
ImmunoPrecise Antibodies Q1 2025 GAAP EPS $(0...
Benzinga Newsdesk
Monday, August 26, 2024
Reported Friday, ImmunoPrecise Antibodies Rec...
Benzinga Newsdesk
Wednesday, August 14, 2024
Benchmark Maintains Speculative Buy on Immuno...
Benzinga Newsdesk
Tuesday, July 30, 2024
HC Wainwright & Co. Reiterates Buy on ImmunoP...
Benzinga Newsdesk
Monday, July 29, 2024
ImmunoPrecise Antibodies Q4 Loss Of C$(18.05)...
Benzinga Newsdesk
ImmunoPrecise Antibodies Q4 Sales C$6.459M Mi...
Benzinga Newsdesk
Wednesday, July 17, 2024
Reported Earlier, ImmunoPrecise Secures Up To...
Benzinga Newsdesk
Thursday, June 27, 2024
ImmunoPrecise Antibodies Appoints Kristin Tay...
Benzinga Newsdesk
Tuesday, June 25, 2024
ImmunoPrecise Antibodies' BioStrand Subsidiar...
Benzinga Newsdesk
Monday, June 10, 2024
EXCLUSIVE: ImmunoPrecise Antibodies' Subsidiary Releases Software With Customizable Interface For AI-Driven Drug Discovery
Vandana Singh
EXCLUSIVE: ImmunoPrecise Antibodies Tells Ben...
Benzinga Newsdesk
Friday, April 12, 2024
ImmunoPrecise Antibodies And InterSystems Par...
Benzinga Newsdesk
Thursday, March 28, 2024
EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applications
Vandana Singh
EXCLUSIVE: ImmunoPrecise Antibodies Tells Ben...
Benzinga Newsdesk
EXCLUSIVE: ImmunoPrecise Antibodies Tells Ben...
Benzinga Newsdesk
Wednesday, March 20, 2024
IPA Acquires The Carterra LSA Instrument to E...
Benzinga Newsdesk
Friday, March 15, 2024
Benchmark Reiterates Speculative Buy on Immun...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on ImmunoP...
Benzinga Newsdesk
Thursday, March 14, 2024
ImmunoPrecise Antibodies Q3 2024 GAAP EPS $(0...
Benzinga Newsdesk
ImmunoPrecise Antibodies Q3 EPS $(0.11) Misse...
Benzinga Newsdesk
Earnings Scheduled For March 14, 2024
Benzinga Insights
Wednesday, March 13, 2024
Earnings Outlook For ImmunoPrecise Antibodies
Benzinga Insights
Thursday, March 07, 2024
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
ImmunoPrecise Antibodies shares are trading h...
Benzinga Newsdesk
IPA's subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology
Charles Gross
Monday, February 12, 2024
ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discovery
Faith Ashmore
-
Sponsored
Wednesday, January 10, 2024
ImmunoPrecise Antibodies Reports A 19.9% Reve...
Benzinga Newsdesk
Tuesday, January 09, 2024
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms
Faith Ashmore
-
Sponsored
Thursday, December 14, 2023
ImmunoPrecise Antibodies Q2 EPS $(0.07) Beats...
Benzinga Newsdesk
Earnings Scheduled For December 14, 2023
Benzinga Insights
Wednesday, December 13, 2023
Earnings Preview For ImmunoPrecise Antibodies
Benzinga Insights
Wednesday, December 06, 2023
Gold Moves Higher; Campbell Soup Earnings Top Expectations
Lisa Levin
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Why ImmunoPrecise Antibodies (IPA) Stock Is Down 20% Today
Henry Khederian
Crude Oil Down 4%; Pharvaris Shares Spike Higher
Lisa Levin
US Stocks Higher; Private Payrolls Rise By 103,000 In November
Lisa Levin
IPA shares are trading lower after the compan...
Benzinga Newsdesk
Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Lisa Levin
ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14
Faith Ashmore
-
Sponsored
IPA Prices Public Offering Of 1.10M Common Sh...
Benzinga Newsdesk
Show More